What milestones has Salspera, Inc. set for Saltikva?

The next milestone is starting the pivotal Phase 3 of Saltikva in stage IV pancreatic cancer, followed by Phase 2 studies of Saltikva in osteosarcoma, colorectal cancer and other solid tumors under the expanded IND. No dates have been published.